• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Vascular dysfunction in glycogen storage disease type I.I型糖原贮积病中的血管功能障碍。
J Pediatr. 2009 Apr;154(4):588-91. doi: 10.1016/j.jpeds.2008.10.048. Epub 2008 Dec 21.
2
Prediction of premature atherosclerosis by endothelial dysfunction and increased intima-media thickness in glycogen storage disease types Ia and III.通过内皮功能障碍和糖原贮积病Ia型和III型中内膜中层厚度增加来预测动脉粥样硬化过早发生
Turk J Pediatr. 2007 Apr-Jun;49(2):115-9.
3
Glycogen storage disease type I patients with hyperlipidemia have no signs of early vascular dysfunction and premature atherosclerosis.糖原贮积病 I 型伴高脂血症患者无早期血管功能障碍和早发动脉粥样硬化迹象。
Nutr Metab Cardiovasc Dis. 2021 Nov 29;31(12):3384-3392. doi: 10.1016/j.numecd.2021.08.027. Epub 2021 Aug 13.
4
Common carotid artery intima-media thickness is not increased but distensibility is reduced in normotensive patients with type 2 diabetes compared with control subjects.与对照组相比,2型糖尿病血压正常患者的颈总动脉内膜中层厚度未增加,但扩张性降低。
J Int Med Res. 2010 May-Jun;38(3):860-9. doi: 10.1177/147323001003800312.
5
Early detection of atherosclerosis in type 2 diabetic patients by endothelial dysfunction and intima-media thickness.通过内皮功能障碍和内膜中层厚度早期检测2型糖尿病患者的动脉粥样硬化。
Rom J Intern Med. 2004;42(2):343-54.
6
Interrelationship between noninvasive predictors of atherosclerosis: transthoracic coronary flow reserve, flow-mediated dilation, carotid intima-media thickness, aortic stiffness, aortic distensibility, elastic modulus, and brachial artery diameter.动脉粥样硬化无创预测指标之间的相互关系:经胸冠状动脉血流储备、血流介导的血管舒张功能、颈动脉内膜中层厚度、主动脉僵硬度、主动脉扩张性、弹性模量和肱动脉直径。
Echocardiography. 2006 Nov;23(10):835-42. doi: 10.1111/j.1540-8175.2006.00342.x.
7
Endothelial dysfunction predictor of structural changes of arterial wall in type I diabetes.1型糖尿病患者动脉壁结构改变的内皮功能障碍预测指标
Int Angiol. 2006 Sep;25(3):280-6.
8
[Ultrasonographic evaluation of atherosclerotic changes in carotid and brachial arteries in children with type 1 diabetes].[1型糖尿病患儿颈动脉和肱动脉粥样硬化改变的超声评估]
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw. 2004;10(1):21-8.
9
Flow-mediated vasodilatation of the brachial artery and intima-media thickness of carotid artery in never-treated subjects.未经治疗的受试者肱动脉血流介导的血管舒张和颈动脉内膜中层厚度
Int Angiol. 2006 Sep;25(3):274-9.
10
[Ultrasonographic evaluation of atherosclerotic changes in carotid and brachial arteries in children with growth hormone deficiency before GH replacement therapy].[生长激素替代治疗前生长激素缺乏儿童颈动脉和肱动脉粥样硬化改变的超声评估]
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw. 2005;11(2):85-90.

引用本文的文献

1
Morphofunctional Assessment beyond Malnutrition: Fat Mass Assessment in Adult Patients with Phenylketonuria-Systematic Review.肥胖症评估在苯丙酮尿症成年患者中的应用:系统综述
Nutrients. 2024 Jun 11;16(12):1833. doi: 10.3390/nu16121833.
2
Glycogen storage diseases: An update.糖原贮积病:更新。
World J Gastroenterol. 2023 Jul 7;29(25):3932-3963. doi: 10.3748/wjg.v29.i25.3932.
3
Glycogen Storage Disease Type I (Von Gierke disease): Report of Two Cases with Severe Dyslipidemia.I型糖原贮积病(冯·吉尔克病):两例严重血脂异常病例报告
Arq Bras Cardiol. 2020 Apr;114(4 Suppl 1):23-26. doi: 10.36660/abc.20190037. Epub 2020 May 18.
4
Lipids in hepatic glycogen storage diseases: pathophysiology, monitoring of dietary management and future directions.肝糖原贮积病中的脂质:病理生理学、饮食管理监测及未来方向
J Inherit Metab Dis. 2015 May;38(3):537-43. doi: 10.1007/s10545-015-9811-2. Epub 2015 Jan 30.
5
Glycogen Storage Disease type 1a - a secondary cause for hyperlipidemia: report of five cases.1a型糖原贮积病——高脂血症的一个次要病因:5例报告
J Diabetes Metab Disord. 2013 Jun 6;12(1):25. doi: 10.1186/2251-6581-12-25.
6
iPS cell modeling of cardiometabolic diseases.诱导多能干细胞在心脏代谢疾病中的建模研究。
J Cardiovasc Transl Res. 2013 Feb;6(1):46-53. doi: 10.1007/s12265-012-9413-4. Epub 2012 Oct 16.
7
Glucose-6-phosphatase deficiency.葡萄糖-6-磷酸酶缺乏症。
Orphanet J Rare Dis. 2011 May 20;6:27. doi: 10.1186/1750-1172-6-27.
8
Dietary dilemmas in the management of glycogen storage disease type I.糖原贮积病 I 型治疗中的饮食难题。
J Inherit Metab Dis. 2011 Jun;34(3):621-9. doi: 10.1007/s10545-011-9322-8. Epub 2011 Apr 14.

本文引用的文献

1
Increased de novo lipogenesis and delayed conversion of large VLDL into intermediate density lipoprotein particles contribute to hyperlipidemia in glycogen storage disease type 1a.1a型糖原贮积病中,新生脂肪生成增加以及大颗粒极低密度脂蛋白向中间密度脂蛋白颗粒的转化延迟导致了高脂血症。
Pediatr Res. 2008 Jun;63(6):702-7. doi: 10.1203/PDR.0b013e31816c9013.
2
The paradoxical relationship between serum uric acid and cardiovascular disease.血清尿酸与心血管疾病之间的矛盾关系。
Clin Chim Acta. 2008 Jun;392(1-2):1-7. doi: 10.1016/j.cca.2008.02.024. Epub 2008 Mar 7.
3
Increased scavenger receptor class B type I-mediated cellular cholesterol efflux and antioxidant capacity in the sera of glycogen storage disease type Ia patients.Ia型糖原贮积病患者血清中清道夫受体B类I型介导的细胞胆固醇外流增加及抗氧化能力增强。
Mol Genet Metab. 2006 Nov;89(3):233-8. doi: 10.1016/j.ymgme.2006.05.002. Epub 2006 Jun 14.
4
Decreased plasma concentration of von Willebrand factor antigen (VWF:Ag) in patients with glycogen storage disease type Ia.Ia型糖原贮积病患者血管性血友病因子抗原(VWF:Ag)的血浆浓度降低。
J Inherit Metab Dis. 2005;28(6):945-50. doi: 10.1007/s10545-005-0184-9.
5
Radial artery tonometry demonstrates arterial stiffness in children with type 1 diabetes.桡动脉压平测量法可显示1型糖尿病患儿的动脉僵硬度。
Diabetes Care. 2004 Dec;27(12):2911-7. doi: 10.2337/diacare.27.12.2911.
6
Clinical review 168: What vascular ultrasound testing has revealed about pediatric atherogenesis, and a potential clinical role for ultrasound in pediatric risk assessment.临床综述168:血管超声检测对儿童动脉粥样硬化形成的揭示,以及超声在儿童风险评估中的潜在临床作用。
J Clin Endocrinol Metab. 2004 Jul;89(7):3089-95. doi: 10.1210/jc.2003-030644.
7
Increased levels of hemostatic proteins are independent of inflammation in glycogen storage disease type Ia.
J Pediatr Gastroenterol Nutr. 2003 Nov;37(5):566-70. doi: 10.1097/00005176-200311000-00011.
8
Changes in coagulability of the blood during various phases of ischaemic heart-disease.
Lancet. 1959 May 30;1(7083):1115-8. doi: 10.1016/s0140-6736(59)90706-8.
9
Glycogen storage diseases.糖原贮积病
Rev Endocr Metab Disord. 2003 Mar;4(1):95-102. doi: 10.1023/a:1021831621210.
10
Vasoactive substances: nitric oxide and endothelial dysfunction in atherosclerosis.血管活性物质:一氧化氮与动脉粥样硬化中的内皮功能障碍
Vascul Pharmacol. 2002 May;38(5):259-69. doi: 10.1016/s1537-1891(02)00250-1.

I型糖原贮积病中的血管功能障碍。

Vascular dysfunction in glycogen storage disease type I.

作者信息

Bernier Angelina V, Correia Catherine E, Haller Michael J, Theriaque Douglas W, Shuster Jonathan J, Weinstein David A

机构信息

Division of Pediatric Endocrinology and Glycogen Storage Disease Program, Department of Pediatrics, University of Florida, Gainesville, FL 32610-0296, USA.

出版信息

J Pediatr. 2009 Apr;154(4):588-91. doi: 10.1016/j.jpeds.2008.10.048. Epub 2008 Dec 21.

DOI:10.1016/j.jpeds.2008.10.048
PMID:19101686
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3607442/
Abstract

OBJECTIVE

To determine cardiovascular disease risk in a larger cohort of patients with glycogen storage disease (GSD) I through the use of noninvasive measures of arterial function and anatomy.

STUDY DESIGN

Carotid intima media thickness (IMT), radial artery tonometry, and brachial artery reactivity were performed in 28 patients with GSD I (13F/15M, mean age 23 years) and 23 control subjects (19F/4M, mean age 23 years).

RESULTS

The primary outcome measure, mean left distal IMT was greater in the GSD cohort (0.500+/-0.055 mm) than in the control group (0.457+/-0.039 mm) (P= .002, adjusted for age, sex, and body mass index). Mean augmentation index measured by radial artery tonometry was higher in the GSD cohort (16.4%+/-14.0%) than in the control group (2.4%+/-8.7%) (P< .001). No significant difference was observed between mean brachial artery reactivity in the GSD cohort (6.3%+/-4.9% change) versus control subjects (6.6%+/-5.1% change) (P= .46).

CONCLUSIONS

GSD I is associated with arterial dysfunction evident by increased IMT and augmentation index. Patients with GSD I may be at increased risk for cardiovascular disease.

摘要

目的

通过使用动脉功能和解剖结构的非侵入性测量方法,确定更大队列的糖原贮积病(GSD)I型患者的心血管疾病风险。

研究设计

对28例GSD I型患者(13名女性/15名男性,平均年龄23岁)和23名对照者(19名女性/4名男性,平均年龄23岁)进行颈动脉内膜中层厚度(IMT)、桡动脉张力测量和肱动脉反应性检测。

结果

主要结局指标,GSD队列的平均左远端IMT(0.500±0.055mm)大于对照组(0.457±0.039mm)(P = .002,校正年龄、性别和体重指数后)。通过桡动脉张力测量的平均增强指数在GSD队列中(16.4%±14.0%)高于对照组(2.4%±8.7%)(P < .001)。GSD队列的平均肱动脉反应性(变化6.3%±4.9%)与对照者(变化6.6%±5.1%)之间未观察到显著差异(P = .46)。

结论

GSD I型与IMT增加和增强指数升高所显示的动脉功能障碍相关。GSD I型患者心血管疾病风险可能增加。